Through investment and project management, we amplify the value of pre-commercial projects with high-value potential to a stage where they can commercialize.
Bridging the translational gap
Life science translation faces a persistent gap between basic research or drug discovery and clinical proof-of-concept. The scarcity of private investment in early-stage medical devices and diagnostic development drives the need for inventors to leverage alternative funding sources to advance innovation. Amplify will provide the resources to develop promising therapeutics, medical devices, and diagnostics, focusing on discoveries from Mass General Brigham hospitals, including Massachusetts General Hospital and Brigham and Women’s Hospital.
We will develop a translational plan alongside the principal investigator (PI) and then will operate the project on their behalf.
Dione T. Kobayashi, PhD, Partner
Amplify seeks to work closely with Mass General Brigham investigators to develop their innovative therapeutic projects into commercializable assets. Just as innovation takes many forms, Amplify projects will span diseases and therapeutic modalities. Investigators with projects that aspire to create therapies for patients who require new and better medicines are encouraged to contact Dr. Kobayashi.
Erin McKenna, MBA, Operating Partner
Amplify is interested in working with Mass General Brigham investigators to develop and advance medical devices and diagnostic technologies with the ability to have a significant impact on improving patient care. Amplify projects can serve a variety of unmet clinical needs and utilize a broad range of technology types. Investigators with projects with transformative potential are encouraged to contact Erin McKenna.
Our team
-
Managing Partner
-
Head of Therapeutics and Partner, Amplify
-
Head of Medical Devices and Operating Partner, Amplify
-
Associate, Commercial Lead, Amplify
-
Operator in Residence, Biologics Lead, Amplify
-
Operator in Residence, Chemistry Lead, Amplify